Rebound Phenomena after Anticoagulant Therapy

نویسنده

  • JOHN MARSHALL
چکیده

T HE occurrence of inyocardial inifaretion and embolic incidents in patients with ischemic heart disease after cessation of anticoagulant therapy is well recognized.1-6 Likewise, the recurrence of intermittent ischemic attacks in the carotid and vertebro-basilar territory when anticoagulant treatment has been stopped has been described.7 These experiences have led to the suggestion that following the cessation of anticoagulant therapy there is a "rebound phenomenon" during which further clinical ineidents are more likely to occur. Ascertaining whether such a phenomenon exists meets with two difficulties. The first is that if anticoagulant therapy is effectively suppressing a continuing tendency to thromboembolism, stopping therapy allows the tendency to reassert itself; hence there is likely to be a recurrence of clinical incidents. It has indeed been snggested that the "rebound phenomenon " is simply "'a return to the status quo ante" and not a rebound in the usual sense.8 But others have envisaged "a rebound hypercoagulable state, " at least when therapy is stopped because of hemorrhage.9 Evidence for a state of hypercoagulability following cessation of heparin therapy in dogs has been found,10 but attempts to find hematologic evidence of a similar state in man have not yet been successful.1 The second difficulty is that atherosclerosis is a progressive condition, hence the disease must of necessity be more advanced after a period of therapy that is suppressive and not curative, than it was before. An apparent increase in thrombo-embolic incidents after cessation of anticoagulant therapy might well be due to the more advanced stage of the disease.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The rebound phenomenon-fact or fancy? Experience with discontinuation of long-term anticoagulation therapy after myocardial infarction.

THERE IS considerable controversy regarding the recurrence of thromboembolic episodes following discontinuation of long-term anticoagulant therapy. Most reports from this country1-9 (table 1), claim a high incidence of thromboembolism after cessation of long-term anticoagulants. This is in striking contrast to what has been reported in some European studies.'0 12 The question of a rebound state...

متن کامل

Sensory-Neural Hearing Loss as an Early Rebound Relapse after Fingolimod Cessation in Multiple Sclerosis

Introduction: Multiple sclerosis (MS) is a lifelong disease of the brain and spinal cord. Fingolimod is an oral drug which modulates the S1P receptor and is used for relapsing remitting form of MS and can causes rebound activity if it is ceased even in a short period of washout time.   Case Report: Here, we introduce a young girl, a known case of MS, who developed revers...

متن کامل

A Medwatch review of reported events in patients who discontinued rivaroxaban (XARELTO) therapy in response to legal advertising

Introduction Rivaroxaban (XARELTO) is an oral Factor Xa inhibitor anticoagulant. Studied in over 85,000 patients, it was initially approved by the FDA in 2011 and is indicated to treat or prevent thrombosis in a variety of clinical settings; and when appropriately prescribed, for example in patients with atrial fibrillation, rivaroxaban has similar anticoagulant efficacy, with a lower risk of i...

متن کامل

Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.

OBJECTIVES This study compared rebound coagulation in patients with acute coronary syndrome patients after discontinuation of unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH). BACKGROUND Up to a quarter of patients hospitalized for unstable angina experience recurrent ischemia after discontinuation of UFH or LMWH therapy, which may be the result of rebound coagulation activ...

متن کامل

The risk of interrupting long-term anticoagulant treatment. A rebound hypercoagulable state following hemorrhage.

LONG-TERM anticoagulation is an accepted mode of treatment for prevention of emboli from fibrillating hearts, thrombotic occlusions in arteriosclerotic disorders, and pulmonary emboli in phlebitis. The degree of success in coronary artery disease is somewhat disappointing because it does not completely eradicate death from this cause although the incidence of thrombotic complications is clearly...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2005